NATO STANAG 2242

POLICY FOR THE CHEMOPROPHYLAXIS AND IMMUNOTHERAPY OF NATO PERSONNEL AGAINST BIOLOGICAL WARFARE AGENTS - ED 1

contributor author	NATO - North Atlantic Treaty Organization
date accessioned	2017-09-04T17:35:36Z
date available	2017-09-04T17:35:36Z
date copyright	05/10/2005
date issued	2005
identifier other	DILXHBAAAAAAAAAA.pdf
identifier uri	http://mapnamagz.yabesh.ir/std;query=autho1826AF67FCdardstandardsfen/handle/yse/158527
description abstract	The aim of this agreement is to develop a unified approach in NATO doctrine and policy in the use of chemoprophylaxis and immunotherapy by NATO personnel against Biological Warfare (BW) agents that cause infectious disease.
language	English
title	NATO STANAG 2242	num
title	POLICY FOR THE CHEMOPROPHYLAXIS AND IMMUNOTHERAPY OF NATO PERSONNEL AGAINST BIOLOGICAL WARFARE AGENTS - ED 1	en
type	standard
page	10
status	Active
tree	NATO - North Atlantic Treaty Organization:;2005
contenttype	fulltext